Search results
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 6 days agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 3 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Super 6: RedHawks' Fernandez delivers recording-tying hit performance with family in attendance
The Fargo Forum· 1 day agoFernandez delivered a memorable peformance with a hit for each one. "Knowing my family was there to...
Researchers develop mRNA vaccine for strain of avian flu | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 21 hours agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
Benzinga via Yahoo Finance· 5 days agoTuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 7 days agoNovavax is pursuing full approval for Nuvaxovid in the U.S. It will likely earn the nod, but how...
The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar...
Zacks via Yahoo Finance· 2 days agoPerformance The Nasdaq Biotechnology Index has moved up 0.83% in the past five trading sessions and ...
Second US Human Bird Flu Infection Reported in Michigan
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- A Michigan farmworker tested positive with bird flu, the second person to contract...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 2 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it was pulling the vaccine ...